Pfizer, US in talks for 'multibillion-dollar' supply deal for COVID-19 pill

Pfizer, US in talks for 'multibillion-dollar' supply deal for COVID-19 pill

Source: 
Fierce Pharma
snippet: 

Pfizer has already reeled in tens of billions with its COVID-19 vaccine during the pandemic. Now, it's reportedly on the verge of striking a major deal to supply its therapeutic hopeful to the United States.

The Biden administration is expected to unveil plans this week to buy 10 million courses of Pfizer's COVID pill, The Washington Post reports, citing two people close to the matter. That would amount to a roughly $5 billion deal for Pfizer, assuming the drug wins FDA authorization and the U.S. purchases it at the $500-per-course price cited by a Post source.